Breaking News Instant updates and real-time market news.

ADAP

Adaptimmune

$3.51 /

+0.09 (+2.63%)

08:28
02/27/20
02/27
08:28
02/27/20
08:28

Adaptimmune expects to launch ADP-A2M4 for sarcoma in 2022

Based on compelling response data in synovial sarcoma from the Phase 1 trial announced in May of last year, and updated at ESMO and CTOS, the Phase 2 SPEARHEAD-1 trial was initiated with ADP-A2M4 in synovial sarcoma and myxoid/ round cell liposarcoma. The product was granted Orphan Drug Designation, for the treatment of soft tissue sarcomas, and Regenerative Medicine Advanced Therapy designation, for synovial sarcoma, by the US FDA. The Company aims to launch ADP-A2M4 for sarcoma in 2022. In January of this year, partial responses in liver, melanoma, gastro-esophageal junction, and head and neck cancers were reported. These early data in multiple indications demonstrate the potential of Adaptimmune's SPEAR T-cell platform across multiple targets and a range of solid tumors. Further updated data will be presented at upcoming medical / scientific meetings.

  • 27

    Feb

ADAP Adaptimmune
$3.51 /

+0.09 (+2.63%)

10/23/19
Adaptimmune management to meet with SunTrust
08/02/19
Fly Intel: Top five analyst downgrades
08/02/19 Guggenheim
Adaptimmune downgraded to Neutral on low near-term visibility at Guggenheim
08/01/19 Guggenheim
Adaptimmune downgraded to Neutral from Buy at Guggenheim

TODAY'S FREE FLY STORIES

Upgrade
BNY Mellon upgraded to Outperform from Market Perform at Keefe Bruyette » 08:07
04/01/20
04/01
08:07
04/01/20
08:07
BK

BNY Mellon

$33.68 /

-0.31 (-0.91%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Soliton postpones launch of RAP tattoo removal device » 08:07
04/01/20
04/01
08:07
04/01/20
08:07
SOLY

Soliton

$7.95 /

-0.48 (-5.69%)

Soliton provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Dare Bioscience receives third notice of award from NIH division for Ovaprene » 08:07
04/01/20
04/01
08:07
04/01/20
08:07
DARE

Dare Bioscience

$0.86 /

-0.0345 (-3.87%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

Dare Bioscience (DARE)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
JPMorgan upgraded to Outperform from Market Perform at Keefe Bruyette » 08:07
04/01/20
04/01
08:07
04/01/20
08:07
JPM

JPMorgan

$90.30 /

-3.14 (-3.36%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Semtech participates in a conference call with Piper Sandler » 08:06
04/01/20
04/01
08:06
04/01/20
08:06
SMTC

Semtech

$37.48 /

+0.79 (+2.15%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
State Street downgraded to Market Perform from Outperform at Keefe Bruyette » 08:06
04/01/20
04/01
08:06
04/01/20
08:06
STT

State Street

$53.18 /

+2.45 (+4.83%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Heat Biologics announces formation of COVID-19 advisory board » 08:06
04/01/20
04/01
08:06
04/01/20
08:06
HTBX

Heat Biologics

$0.57 /

-0.0026 (-0.45%)

Heat Biologics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Sixt initiated with a Buy at Jefferies » 08:06
04/01/20
04/01
08:06
04/01/20
08:06
SIXGF

Sixt

$0.00 /

+ (+0.00%)

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Arcadia Biosciences names Randy Shultz, Ph.D. as Chief Technology Officer » 08:06
04/01/20
04/01
08:06
04/01/20
08:06
RKDA

Arcadia Biosciences

$2.83 /

-0.04 (-1.39%)

Arcadia Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Paramount Group to sell 10% interest in 1633 Broadway » 08:05
04/01/20
04/01
08:05
04/01/20
08:05
PGRE

Paramount Group

$8.77 /

-0.06 (-0.68%)

Paramount Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Aytu BioScience receives initial shipment of 100K COVID-19 IgG/IgM Rapid Test » 08:05
04/01/20
04/01
08:05
04/01/20
08:05
AYTU

Aytu BioScience

$1.52 /

-0.16 (-9.55%)

Aytu BioScience announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Tractor Supply upgraded to Outperform at Oppenheimer » 08:04
04/01/20
04/01
08:04
04/01/20
08:04
TSCO

Tractor Supply

$84.52 /

-0.92 (-1.08%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Paratek Pharmaceuticals announces initiation of funding from BARDA » 08:04
04/01/20
04/01
08:04
04/01/20
08:04
PRTK

Paratek Pharmaceuticals

$3.12 /

+ (+0.00%)

Paratek Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Seneca Biopharma names Matthew Kalnik, Ph.D. as COO, Dane Saglio as CFO » 08:04
04/01/20
04/01
08:04
04/01/20
08:04
SNCA

Seneca Biopharma

$0.63 /

-0.0043 (-0.67%)

, RGRX

RegeneRx

$0.00 /

+ (+0.00%)

Seneca Biopharma (SNCA)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
UniFirst not providing guidance for remainder of 2020 » 08:03
04/01/20
04/01
08:03
04/01/20
08:03
UNF

UniFirst

$149.70 /

+3.7 (+2.53%)

CEO Steven Sintros…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
UniFirst reports Q2 diluted EPS $1.82, consensus $1.65 » 08:02
04/01/20
04/01
08:02
04/01/20
08:02
UNF

UniFirst

$149.70 /

+3.7 (+2.53%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Janney Montgomery Scott downgrades four BDCs based on COVID-19 recession » 08:02
04/01/20
04/01
08:02
04/01/20
08:02
BCSF

Bain Capital Specialty Finance

$9.27 /

+0.01 (+0.11%)

, MRCC

Monroe Capital

$7.01 /

+0.405 (+6.14%)

, OFS

OFS Capital

$4.05 /

-0.16 (-3.80%)

, SCM

Stellus Capital

$7.30 /

-0.09 (-1.22%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Willis Towers Watson price target lowered to $232 from $240 at Wells Fargo » 08:02
04/01/20
04/01
08:02
04/01/20
08:02
WLTW

Willis Towers Watson

/

+

Wells Fargo analyst Elyse…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Travelers price target lowered to $110 from $130 at Wells Fargo » 08:01
04/01/20
04/01
08:01
04/01/20
08:01
TRV

Travelers

$99.36 /

-3.36 (-3.27%)

Wells Fargo analyst Elyse…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Northland downgrades Target Hospitality on oil market deterioration » 08:00
04/01/20
04/01
08:00
04/01/20
08:00
TH

Target Hospitality

$1.98 /

+0.13 (+7.03%)

Northland analyst Jeff…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Apple put buyer realizes 43% same-day gains » 08:00
04/01/20
04/01
08:00
04/01/20
08:00
AAPL

Apple

$254.28 /

-0.61 (-0.24%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
ADP Employment Report employment to be reported at 08:15 » 08:00
04/01/20
04/01
08:00
04/01/20
08:00

March ADP Employment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Whiting Petroleum trading halted, news pending  07:59
04/01/20
04/01
07:59
04/01/20
07:59
WLL

Whiting Petroleum

$0.67 /

+0.0061 (+0.92%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Allstate price target lowered to $107 from $120 at Wells Fargo » 07:59
04/01/20
04/01
07:59
04/01/20
07:59
ALL

Allstate

$91.81 /

-2.69 (-2.85%)

Wells Fargo analyst Elyse…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Apple earnings target cut at Argus » 07:58
04/01/20
04/01
07:58
04/01/20
07:58
AAPL

Apple

/

+

Argus analyst Jim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.